Advances in the therapeutic use of mammalian target of rapamycin (mTOR) inhibitors in dermatology
Keywords: درمان پوستی; antiproliferative; autoimmune; drug repurposing; genodermatosis; immunosuppression; inflammatory; mammalian target of rapamycin; neoplasia; percutaneous therapy; rapamycin; sirolimus; vascular anomaliesAkt, protein kinase B; BHD, Birt-Hogg-Dubé syndrome;